Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus ...

A GlobalData analyst has warned that Trump's second term could see major changes in US healthcare, and RFK could rock the ...

AlloVir has entered into a definitive agreement for the acquisition of the complete outstanding shares of Kalaris ...

We explore the immense potential of gamma delta T cells, and the challenges in sourcing and scaling up sufficient volumes to ...

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in ...

ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food and Drug Administration (FDA) aiming to secure ...

Analysis of future trends highlights that the cold chain logistics sector is at a critical juncture, with tech advancements driving change.

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001to treat uveitic ...

GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

Trump has not been vocal about healthcare policies but indicated that RFK Jr. will have a big influence on the sector.